Key facts
- Ciba Health’s last known valuation is $39.8M (Mar 2024).
- It has raised $17.5M across 5 recorded rounds; the latest was Seed Round ($2.3M) in Sep 2025.
- Notable investors include Plug and Play Tech Center, Endless Frontier Labs, InsurTech NY, E12 Venture Capital, Cure Xchange Challenge — 11 tracked in total.
- Ciba Health has filed 4 Form Ds with the SEC since 2023, most recently Apr 2025 ($1.8M sold to 4 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Ciba Health
Funding rounds
5 roundsAbout Ciba Health
Developer of a precision digital health platform designed to transform the treatment of chronic disease through root cause resolution. The company offers AI-enabled analytics, biomarker testing, and a multidisciplinary care team including physicians, dietitians, health coaches, and behavioral specialists, enabling payers, employers, and health systems to improve health outcomes and reduce the overall cost of care.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 54
- Website
- cibahealth.com/
- Ownership
- Privately Held (backing)
Ciba Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ciba Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ciba Health in its N-PORT filings yet. We sweep new filings monthly.